{"nct_id":"NCT03345849","title":"A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2017-12-07","start_date_type":"ACTUAL","primary_completion_date":"2021-10-15","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}